ArticleScientific reports2024

Combined oral low-dose cyclophosphamide endocrine therapy may improve clinical response among patients with metastatic breast cancer via Tregs in TLSs.

Yuze Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.